Imfinzi for Non Small Cell Lung Cancer User Reviews
- jkp...
- Taken for 6 months to 1 year
- August 15, 2024
"Cancer in remission just before 10th treatment. Many skin problems. Dry, cracking skin on sides and bottom of feet. Dry skin on arms and legs. Occasional mild headaches, terrible problems sleeping at night. All problems on mild side."
- Anonymous
- Taken for 6 months to 1 year
- April 1, 2024
"Had 12 treatments after completion of chemoradiation. Medication was well tolerated with minimal side effects."
Frequently asked questions
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about Imfinzi (durvalumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
"Also using to treat myeloma. Started taking late 2016. Seems to keep both cancers at bay. I have had some very strange lung infections. Not sure if related to treatment. My hair is very dry, thin, limp. Dry skin. Frequent urination. Fatigue. Restless nights. Depression. Body aches. I’m a 60-year-old male."